Therapeutic Options in Alzheimer’s Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.